The global PET-CT Scanner Device Market was valued at USD 2.30 billion in 2023 and is projected to reach USD 3.98 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.30% during the forecast period from 2024 to 2032. Market growth is primarily driven by the increasing prevalence of cancer and neurological disorders, continuous advancements in imaging technology, and rising demand for early and accurate disease diagnosis across healthcare systems worldwide.
PET-CT scanners combine functional and anatomical imaging, enabling clinicians to detect diseases at early stages, monitor treatment effectiveness, and personalize therapy plans. The growing emphasis on precision medicine, coupled with higher healthcare expenditure in both developed and emerging economies, continues to accelerate adoption of PET-CT systems across hospitals and diagnostic centers.
Get free Sample Report@ https://www.snsinsider.com/sample-request/4147
Market Dynamics and Technology Trends
Technological innovation remains a key growth catalyst in the PET-CT scanner device market. Advancements such as digital detectors, enhanced image resolution, reduced radiation exposure, and faster scan times are improving diagnostic accuracy and patient comfort. The emergence of total-body PET-CT systems is further transforming clinical research and oncology diagnostics by enabling whole-body imaging in a single scan, significantly reducing examination time while improving data quality.
The integration of artificial intelligence (AI) and advanced software analytics is also reshaping PET-CT workflows. AI-powered reconstruction algorithms and automated image analysis tools are helping clinicians improve diagnostic confidence, reduce interpretation time, and enhance operational efficiency, particularly in high-volume healthcare settings.
By Type: Stationary Systems Lead While Portable Units Gain Momentum
By type, stationary PET-CT scanners dominated the market in 2023, accounting for approximately 70.0% of the total market share. Their dominance is attributed to superior image quality, high throughput, and stable performance, making them the preferred choice for hospitals and large diagnostic centers. These systems are extensively used in oncology, neurology, and cardiology, where precision and reliability are critical for complex diagnostic procedures.
Meanwhile, the portable and mobile PET-CT segment is witnessing robust growth at a CAGR of 10%. Rising demand for point-of-care diagnostics, emergency imaging, and healthcare access in remote or underserved regions is driving adoption. Mobile PET-CT scanners are increasingly used in critical care units and temporary healthcare facilities, supporting faster clinical decision-making.
By Service Provider: Hospitals Remain Key End Users
Hospitals accounted for the largest share of approximately 65.0% in 2023, driven by the availability of advanced infrastructure, specialized departments, and high patient volumes. PET-CT scanners are integral to hospital-based oncology, cardiology, and neurology departments, where comprehensive diagnostic and treatment planning services are required.
At the same time, diagnostic centers are emerging as a fast-growing segment, registering a CAGR of 9%. The shift toward outpatient care, cost-effective imaging services, and shorter waiting times is fueling demand for PET-CT scanners in independent diagnostic facilities, particularly in urban and semi-urban regions.
By Application: Oncology Dominates, Neurology Expands Rapidly
Oncology remained the dominant application area in 2023, accounting for nearly 55.0% of the market share. PET-CT scanners play a critical role in cancer detection, staging, treatment planning, and monitoring therapeutic response. The increasing global cancer burden and rising adoption of personalized oncology therapies continue to support strong demand in this segment.
Neurology is the fastest-growing application segment, expanding at a CAGR of 10%. The rising incidence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy is driving the use of PET-CT imaging to detect metabolic and functional brain changes at early stages, enabling timely intervention and improved patient outcomes.
Regional Analysis: North America Leads, Asia-Pacific Grows Fastest
In 2023, North America held the largest market share of approximately 40.0%, supported by advanced healthcare infrastructure, high technology adoption, and strong investment in diagnostic imaging. The U.S. leads regional growth due to widespread availability of PET-CT systems and a strong focus on early disease detection and precision medicine.
Europe accounted for around 30.0% of the global market, driven by well-established healthcare systems and growing demand for non-invasive diagnostic solutions. Countries such as Germany, France, and the UK continue to invest in advanced imaging technologies to improve clinical outcomes.
The Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of 9%. Rapid healthcare infrastructure development, rising awareness of early diagnosis, and increasing private healthcare investments in countries such as China, India, and Japan are accelerating PET-CT scanner adoption.
Competitive Landscape and Recent Developments
The PET-CT scanner device market is highly competitive, with key players including General Electric Co., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems, Hitachi, United Imaging, Bruker Corporation, Shimadzu Corporation, and Neusoft Medical Systems, among others. Companies are focusing on product innovation, regulatory approvals, and strategic collaborations to strengthen their market position.
Recent advancements include Philips receiving FDA 510(k) clearance in November 2024 for its Spectral CT 7500 RT solution, enhancing radiotherapy precision. Additionally, in June 2024, IRCCS Bologna inaugurated the world’s first total-body PET/CT scanner with a 194 cm axial field of view, marking a significant breakthrough in whole-body imaging and oncology research.
Other Trending Reports
Hematologic Malignancies Market
Lung Cancer Therapeutics Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Rohan Jadhav – Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
